Reply to J.L. Blum et al and S. Lange et al

Affiliations

¹ Ian Krop, Dana-Farber Cancer Institute, Boston, MA; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; William Barlow, University of Washington, Seattle, WA; and Vered Stearns, Johns Hopkins University, Baltimore, MD.

Comment

Ian Krop et al. J Clin Oncol. 2018.

. 2018 Feb 1;36(4):430-431.

doi: 10.1200/JCO.2017.75.8607. Epub 2017 Dec 11.

¹ Ian Krop, Dana-Farber Cancer Institute, Boston, MA; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria, VA; William Barlow, University of Washington, Seattle, WA; and Vered Stearns, Johns Hopkins University, Baltimore, MD.

No abstract available

Comment on

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update.
Krop I, Ismaila N, Andre F, Bast RC, Barlow W, Collyar DE, Hammond ME, Kuderer NM, Liu MC, Mennel RG, Van Poznak C, Wolff AC, Stearns V. Krop I, et al. J Clin Oncol. 2017 Aug 20;35(24):2838-2847. doi: 10.1200/JCO.2017.74.0472. Epub 2017 Jul 10. J Clin Oncol. 2017. PMID: 28692382 Free PMC article.
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy in Early-Stage Invasive Breast Cancer.
Blum JL, Robert N, Andersen J, Favret A, Ward P, Osborne C, Pippen J. Blum JL, et al. J Clin Oncol. 2018 Feb 1;36(4):428-429. doi: 10.1200/JCO.2017.75.3756. Epub 2017 Dec 11. J Clin Oncol. 2018. PMID: 29227724 No abstract available.
Interpretation of the Results of the MINDACT Study and Consequent Recommendations in the Updated ASCO Clinical Practice Guideline.
Lange S, Scheibler F, Fleer D, Windeler J. Lange S, et al. J Clin Oncol. 2018 Feb 1;36(4):429-430. doi: 10.1200/JCO.2017.75.9506. Epub 2017 Dec 11. J Clin Oncol. 2018. PMID: 29227725 No abstract available.